Bcl-xL Cancer Research Results
Bcl-xL, Bcl-xL: Click to Expand ⟱
| Source: |
| Type: pro-survival proteins |
The proteins of BCL-2 family are classified into three subgroups, i.e., the anti-apoptotic/pro-survival proteins represented by BCL-2 and BCL-XL.
BCL-XL overexpressing cells exhibited higher tumors sphere formation capacity and expressed higher levels of some stem cell markers, supporting the concept that BCL-XL plays essential roles in the maintenance of cancer stem cell phenotype.
|
AML, Acute Myeloid Leukemia: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
STAT3↓, cycD1/CCND1↓, Bcl-2↓, Bcl-xL↓, survivin↓, VEGF↓, TumCCA↑, Apoptosis↑, Casp↑, eff↑,
| - |
in-vitro, |
AML, |
U937 |
|
|
|
- |
in-vivo, |
AML, |
NA |
|
|
|
TumCP↓, Apoptosis↑, TumCG↓, PDK1↓, cl‑PARP↑, Bcl-xL↓, Bcl-2↓, Beclin-1↓, ATG3↓, PI3K↓, Akt↓, eff↑,
| - |
in-vitro, |
AML, |
NA |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
DNMT1↓, Sp1/3/4↓, NF-kB↓, Apoptosis↑, Casp↑, Bcl-xL↓, COX2↓, iNOS↓, 5LO↓, TNF-α↓, cycD1/CCND1↓, BioAv↝, TumCG↓,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis ⓘ
PDK1↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 3, Bcl-2↓, 2, Bcl-xL↓, 3, Casp↑, 2, iNOS↓, 1, survivin↓, 1,
Kinase & Signal Transduction ⓘ
Sp1/3/4↓, 1,
Autophagy & Lysosomes ⓘ
ATG3↓, 1, Beclin-1↓, 1,
DNA Damage & Repair ⓘ
DNMT1↓, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 2, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
PI3K↓, 1, STAT3↓, 1, TumCG↓, 2,
Migration ⓘ
5LO↓, 1, TumCP↓, 1,
Angiogenesis & Vasculature ⓘ
VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, NF-kB↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↝, 1, eff↑, 2,
Total Targets: 26
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: Bcl-xL, Bcl-xL
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:2 Cells:% prod#:% Target#:28 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page